Autonomic nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a literature review
- 21 April 2023
- journal article
- review article
- Published by Springer Nature in Neurological Sciences
- Vol. 44 (9) , 3071-3082
Abstract
Background and aims Although dysautonomia is a well-recognized complication of acute demyelinating polyradiculoneuropathy, it is rarely reported and evaluated in chronic demyelinating neuropathies. The purpose of this review is to search and synthesize the current literature on the prevalence and type of autonomic dysfunction (AD) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Methods PubMed and Web of Science were searched for studies reporting AD in CIDP. Results Twelve studies, including 346 patients with CIDP, were found eligible for the review. Seven studies used autonomic tests only as an additional component of the comprehensive clinical evaluation, and found that dysautonomia in CIDP may indicate the presence of a comorbid disease (e.g., diabetes) and facilitate the differentiation of CIDP from other neuropathies (e.g., amyloid neuropathy). Five studies performed quantitative assessment of autonomic function in CIDP as a primary goal. Two studies have used the Composite Autonomic Severity Score (CASS) to assess severity and distribution of dysautonomia. The reported prevalence of dysautonomia in CIDP during quantitative assessment of autonomic function ranged from 25 to 89%, depending on the battery of tests used, with CASS not exceeding 4 points. The abnormalities in autonomic tests indicated both sympathetic and parasympathetic dysfunction and did not correlate with the duration, severity and variant of CIDP. Conclusions Clinical or subclinical involvement of the ANS has been shown to be common and relatively mild in CIDP. The impact of autonomic impairment on disability and of its possible response to therapy in CIDP needs to be further investigated.Keywords
This publication has 48 references indexed in Scilit:
- Autonomic Involvement in Subacute and Chronic Immune-Mediated NeuropathiesAutoimmune Diseases, 2013
- COMPASS 31: A Refined and Abbreviated Composite Autonomic Symptom ScoreMayo Clinic Proceedings, 2012
- Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathyNeurology, 2012
- Clinical and electrophysiological parameters distinguishing acute‐onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathyMuscle & Nerve, 2009
- Incidence and prevalence of CIDP and the association of diabetes mellitusNeurology, 2009
- Characterization of ganglionic acetylcholine receptor autoantibodiesJournal of Neuroimmunology, 2008
- Clinical and subclinical autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathyMuscle & Nerve, 2005
- Cardiovascular autonomic function and sympathetic skin response in chronic inflammatory demyelinating polyradiculoneuropathyMuscle & Nerve, 2002
- Composite Autonomic Scoring Scale for Laboratory Quantification of Generalized Autonomic FailureMayo Clinic Proceedings, 1993
- Autonomic function and unmyelinated fibers in chronic inflammatory demyelinating polyradiculonuropathyMuscle & Nerve, 1990